Patent classifications
A61K33/12
TABLET TO BE SUCKED AND/OR DISSOLVED IN THE MOUTH BASED ON HYALURONIC ACID AND CHONDROITIN SULPHATE AND THEIR SALTS
The present invention relates to a chewable and/or suckable and/or melt-in-mouth tablet based on hyaluronic acid and chondroitin sulphate and/or salts thereof.
TABLET TO BE SUCKED AND/OR DISSOLVED IN THE MOUTH BASED ON HYALURONIC ACID AND CHONDROITIN SULPHATE AND THEIR SALTS
The present invention relates to a chewable and/or suckable and/or melt-in-mouth tablet based on hyaluronic acid and chondroitin sulphate and/or salts thereof.
Antimicrobial skin cream
A cream for treating the skin may include gray clay kaolin; sodium lauryl ether sulfate; blue tartrazine; sodium chloride; menthol; metabisulfite sodium; gelatin; mineral oil; olive oil; oil of cloves; water; green tea; honey; talc; and aloe vera. The cream may also include apple perfume, vitamin E, vitamin D, vitamin C, vitamin B2, vitamin B5, vitamin H, vitamin B6, and vitamin D. The cream may also include fatty acids.
Antimicrobial skin cream
A cream for treating the skin may include gray clay kaolin; sodium lauryl ether sulfate; blue tartrazine; sodium chloride; menthol; metabisulfite sodium; gelatin; mineral oil; olive oil; oil of cloves; water; green tea; honey; talc; and aloe vera. The cream may also include apple perfume, vitamin E, vitamin D, vitamin C, vitamin B2, vitamin B5, vitamin H, vitamin B6, and vitamin D. The cream may also include fatty acids.
Multi-chambered dispenser for the topical application of infused fluid
A multi-chambered dispenser which both retains solid objects such as mineral and ceramic stones in a defined region and also enables fluid communication with the objects is provided. A permeable inner wall may be disposed within an outer chamber to define a barrier preventing the solid objects maintained within the outer chamber from entering an inner chamber defined by the permeable inner wall. Fluid, such as tap or even filtered water, may be poured into the dispenser, and, owing to the permeation of the inner wall, freely communicate with the objects maintained outside of the permeable inner wall to absorb and become infused with various beneficial characteristics comprising the objects. Means for dispensing the infused fluid for topical application may be configured to draw infused fluid out of the dispenser through the inner chamber such that interference of such means by the solid objects is avoided.
Multi-chambered dispenser for the topical application of infused fluid
A multi-chambered dispenser which both retains solid objects such as mineral and ceramic stones in a defined region and also enables fluid communication with the objects is provided. A permeable inner wall may be disposed within an outer chamber to define a barrier preventing the solid objects maintained within the outer chamber from entering an inner chamber defined by the permeable inner wall. Fluid, such as tap or even filtered water, may be poured into the dispenser, and, owing to the permeation of the inner wall, freely communicate with the objects maintained outside of the permeable inner wall to absorb and become infused with various beneficial characteristics comprising the objects. Means for dispensing the infused fluid for topical application may be configured to draw infused fluid out of the dispenser through the inner chamber such that interference of such means by the solid objects is avoided.
Methods and compositions for administering an active agent to the pleura of a patient
A method for administering an active agent to a pleura of a patient includes preparing a composition including a foamable liquid and the active agent, incorporating a gas into the foamable liquid to create a foam containing the active agent, introducing the foam into a pleural cavity of the patient defined by the pleura, and contacting the pleura with the foam. A method of pleurodesis includes introducing a composition into a pleural cavity defined by pleurae of a patient, the composition including a foamable liquid and an active agent capable of causing inflammation and/or adhesion of the pleurae. A composition for treating a pleura of a patient includes a liquid component including a biocompatible composition having a viscosity which increases in response to an increase in temperature, and an active agent capable of causing inflammation and/or adhesion of the pleura.
Methods and compositions for administering an active agent to the pleura of a patient
A method for administering an active agent to a pleura of a patient includes preparing a composition including a foamable liquid and the active agent, incorporating a gas into the foamable liquid to create a foam containing the active agent, introducing the foam into a pleural cavity of the patient defined by the pleura, and contacting the pleura with the foam. A method of pleurodesis includes introducing a composition into a pleural cavity defined by pleurae of a patient, the composition including a foamable liquid and an active agent capable of causing inflammation and/or adhesion of the pleurae. A composition for treating a pleura of a patient includes a liquid component including a biocompatible composition having a viscosity which increases in response to an increase in temperature, and an active agent capable of causing inflammation and/or adhesion of the pleura.
METHOD OF TREATING OR AMELIORATING SKIN CONDITIONS WITH A MAGNETIC DIPOLE STABILIZED SOLUTION
The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.
METHOD OF TREATING OR AMELIORATING SKIN CONDITIONS WITH A MAGNETIC DIPOLE STABILIZED SOLUTION
The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.